MetaCap

BioNTech (BNTX) News

NASDAQ: BNTXHealthcareBiotechnologyUSD

96.96+4.90 (+5.32%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

BNTX news summary

We found 8 recent headlines mentioning BioNTech (BNTX): 2 in the past week and 7 in the past 30 days, most often from Nasdaq. BNTX is making an outsized move today, up 5.32% at $96.96, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "BioNTech Has More Cancer Drugs in Late-Stage Trials Than Most Investors Realize. Is It a Buy Under $100?", was published by Nasdaq on Oct 8, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest BioNTech headlines

Stocks mentioned alongside BNTX

Compare BNTX